Ophthalmic pharma company appoints new VP of clinical development

Ophthalmic pharmaceutical company Aerie Pharmaceuticals named Michelle Senchyna, PhD, vice president of clinical development and medical affairs.

What you should know:

1. Dr. Senchyna will lead the company's clinical development and medical affairs strategy.

2. She comes to Aerie after a tenure as executive director of ophthalmology at Allergan. She previously held positions with Alcon and Panoptica and was a professor at the University of Waterloo in Canada.

3. Dr. Senchyna received restricted stock and stock options in Aerie as part of her compensation package.

More articles on surgery centers: 
3 gastroenterologists joining practices this week
Colorado GI practice expands — 3 insights
3 gastroenterology ASCs, practices opened in January

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months